Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Shares of obesity drugmakers rise ahead of panel
Yahoo/AP
Tuesday, July 13, 2010 - 11:14am
tags:
obsesity, diet drugs, advisory panels, FDA, Qnexa, Vivus, Arena Pharmaceuticals, Contrave, Orexigen
PBMs Win A Big Court Ruling Over Disclosure
Pharmalot
Tuesday, July 13, 2010 - 9:33am
tags:
PBMs
Mass. medical gift law faces possible repeal
CNBC
Tuesday, July 13, 2010 - 9:28am
tags:
Massachusetts, physician gifts
Glaxo Begins Its Defense
Forbes
Tuesday, July 13, 2010 - 9:26am
tags:
GSK, Avandia, diabetes, FDA
Did the Federal Courts Just Legalize Channel Stuffing? One Big Pharma Lawyer Thinks So
BNET Pharma
Tuesday, July 13, 2010 - 9:25am
tags:
channel stuffing, Bristol-Myers Squibb
The Best Investing Ideas in Health Care
Motley Fool
Tuesday, July 13, 2010 - 9:18am
tags:
Biovail, Arena Pharmaceuticals, Neurocrine, Avanir
Vivus Weight-Loss Pill Works - FDA
TheStreet.com
Tuesday, July 13, 2010 - 8:43am
tags:
FDA, diet drugs, obesity, Vivus, advisory panels, Qnexa, Arena Pharmaceuticals, Orexigen, Contrave
Pfizer Medicine Price-Fixing Suit Reinstated by California High Court
Bloomberg
Tuesday, July 13, 2010 - 8:41am
tags:
Pfizer, California, price fixing, lawsuits, Canada
Lilly's Alzheimer's Gamble Aims at $10 Billion Patent Loss
Bloomberg
Tuesday, July 13, 2010 - 8:39am
tags:
Eli Lilly, Alzheimer's disease, semagacestat, solanezumab
Key Vytorin Exec Has Left Merck
Forbes
Tuesday, July 13, 2010 - 8:38am
tags:
Vytorin, Merck, Schering Plough
Six Reasons Avandia Could Stay On the Market
Forbes
Tuesday, July 13, 2010 - 8:37am
tags:
GSK, FDA, diabetes, Avandia
Biotech start-up wins Google's attention--and money
Fierce Biotech
Monday, July 12, 2010 - 2:40pm
tags:
biotech, start-ups, financing, Google, iPierian
Why the FDA Will Likely Reject 3 New Weight Loss Drugs
BNET Pharma
Monday, July 12, 2010 - 2:39pm
tags:
FDA, Vivus, obesity, Qnexa, Orexigen, Arena Pharmaceuticals, Contrave
Drug Pipeline Pulse Check: High Expectations for Novartis
Seeking Alpha
Monday, July 12, 2010 - 2:38pm
tags:
Novartis, Genzyme, Novelos Therapeutics, Alcon
Bristol-Myers Squibb starts recall of Coumadin
Yahoo/AP
Monday, July 12, 2010 - 2:36pm
tags:
recalls, Coumadin, Bristol-Myers Squibb
Former FDA Reviewers Says Glaxo Withheld Study
Pharmalot
Monday, July 12, 2010 - 2:35pm
tags:
GSK, Avandia, diabetes, FDA
Gilead Sciences: Undervalued
Seeking Alpha
Monday, July 12, 2010 - 2:34pm
tags:
Gilead Sciences, Merck, JNJ, Vertex Pharmaceuticals
PhRMA not interested in free-sample limits
Fierce Pharma
Monday, July 12, 2010 - 10:54am
tags:
PhRMA, samples, free sample limits, Europe
Biogen says hemophilia drug meets safety goal
Yahoo/AP
Monday, July 12, 2010 - 10:52am
tags:
Biogen Idec, hemophilia, Biovitrum
Kamada: Wise Strategy or Overly Ambitious?
Seeking Alpha
Monday, July 12, 2010 - 10:41am
tags:
Kamada, Talecris, Glassia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline
Treating Orthopox Viruses - With What?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.